Pulse Biosciences, Inc. Capital Expenditures Incurred but Not yet Paid
Pulse Biosciences, Inc. (PLSE) reported Capital Expenditures Incurred but Not yet Paid of $73.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $45.00K.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $28.00K, a 7.69% increase year-over-year.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was -$2.00K, a 112.50% decline year-over-year.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $26.00K.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $8.00K, a 69.23% decline from fiscal 2024.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $26.00K.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $27.00K, a 0.00% change from fiscal 2021.
- Pulse Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $27.00K, a 35.00% increase from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|
| 2026-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $73.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $8.00K 10-K · filed 2026-02-19 | ||
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $24.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $26.00K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $26.00K 10-K · filed 2026-02-19 | ||
| 2024-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $16.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $27.00K 10-K · filed 2023-03-31 | ||
| 2022-03-31 | $27.00K 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | $27.00K 10-K · filed 2023-03-31 | ||
| 2020-12-31 | $20.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |